• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

袖状胃切除术对人体血浆生长分化因子 15(GDF15)的影响。

Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human.

机构信息

Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, PR China; Institute of Digestive Diseases, Xuzhou Medical University Xuzhou Jiangsu, 221006, PR China.

Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, PR China; Institute of Digestive Diseases, Xuzhou Medical University Xuzhou Jiangsu, 221006, PR China.

出版信息

Am J Surg. 2020 Sep;220(3):725-730. doi: 10.1016/j.amjsurg.2020.01.041. Epub 2020 Jan 28.

DOI:10.1016/j.amjsurg.2020.01.041
PMID:32014297
Abstract

BACKGROUND

Sleeve gastrostomy (SG) induces significant weight loss primarily as a result of increased satiety and reduced food intake. Growth differentiation factor-15 (GDF15) is a satiety hormone which induces a dramatic reduction of food intake and body weight.

OBJECTIVE

To assess the effect of sleeve gastrectomy on plasma GDF 15 level and the association with the weight loss and diabetes control after SG.

METHOD

We assessed plasma GDF15 level in 21 patients (15 with obesity and 6 with obesity and diabetes) before and then at 1, 3 and 12 months after SG.

RESULTS

GDF15 was significantly increased at 1 month after SG compared to before surgery level (301.9 ± 135.2 pg/ml vs 215.1 ± 119.9 pg/ml, respectively p<0.05) and increased even further at 3 months (338.86 ± 131.14 pg/ml, p<0.01) and remain elevated at 12 months (329.39 ± 152.1 pg/ml p<0.05) after SG. At 3 months after surgery, the increased GDF15 level was correlated with the magnitude of BMI loss (r = 0.204, p<0.05).

CONCLUSION

SG induces a significant increase in GDF15 level which is correlated with the magnitude of BMI loss.

摘要

背景

袖状胃切除术(SG)主要通过增加饱腹感和减少食物摄入量来引起显著的体重减轻。生长分化因子 15(GDF15)是一种饱腹感激素,可显著减少食物摄入和体重。

目的

评估袖状胃切除术对血浆 GDF15 水平的影响,以及与 SG 后体重减轻和糖尿病控制的关系。

方法

我们评估了 21 例患者(15 例肥胖和 6 例肥胖合并糖尿病)在 SG 前后 1、3 和 12 个月的血浆 GDF15 水平。

结果

与术前水平相比,SG 后 1 个月 GDF15 显著升高(301.9±135.2 pg/ml 比 215.1±119.9 pg/ml,p<0.05),3 个月时进一步升高(338.86±131.14 pg/ml,p<0.01),SG 后 12 个月仍升高(329.39±152.1 pg/ml,p<0.05)。术后 3 个月,GDF15 水平升高与 BMI 减轻幅度相关(r=0.204,p<0.05)。

结论

SG 诱导 GDF15 水平显著升高,与 BMI 减轻幅度相关。

相似文献

1
Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human.袖状胃切除术对人体血浆生长分化因子 15(GDF15)的影响。
Am J Surg. 2020 Sep;220(3):725-730. doi: 10.1016/j.amjsurg.2020.01.041. Epub 2020 Jan 28.
2
Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals.减重手术后的患者和匹配的对照组的血浆 GDF15 水平相似,不受饮食影响。
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E443-E452. doi: 10.1152/ajpendo.00190.2021. Epub 2021 Aug 9.
3
Effect of bariatric surgery on plasma GDF15 in humans.减重手术对人体 GDF15 血浆水平的影响。
Am J Physiol Endocrinol Metab. 2019 Apr 1;316(4):E615-E621. doi: 10.1152/ajpendo.00010.2019. Epub 2019 Feb 5.
4
The effect of bariatric surgery on the expression of Growth Differentiation Factor-15/Macrophage-Inhibitory Cytokine-1 (GDF-15/MIC-1) in rat.减重手术对大鼠生长分化因子 15/巨噬细胞抑制因子 1(GDF-15/MIC-1)表达的影响。
Surg Endosc. 2022 Aug;36(8):6205-6213. doi: 10.1007/s00464-022-09036-w. Epub 2022 Jan 14.
5
GDF15 and Cortisol Response to Meal Tolerance Test in Post-Sleeve Gastrectomy Patients with Weight Regain.胃旁路术后体重反弹患者对餐耐量试验的 GDF15 和皮质醇反应。
Obes Surg. 2022 Aug;32(8):2641-2648. doi: 10.1007/s11695-022-06140-7. Epub 2022 Jun 8.
6
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.GDF15 与利拉鲁肽协同作用,但不是减肥手术诱导小鼠体重减轻所必需的。
Mol Metab. 2019 Mar;21:13-21. doi: 10.1016/j.molmet.2019.01.003. Epub 2019 Jan 14.
7
Elevated plasma endothelin-1 is associated with reduced weight loss post vertical sleeve gastrectomy.血浆内皮素-1 水平升高与垂直袖状胃切除术减肥效果降低有关。
Surg Obes Relat Dis. 2019 Jul;15(7):1044-1050. doi: 10.1016/j.soard.2019.03.047. Epub 2019 Apr 9.
8
Changes in Food Choice, Taste, Desire, and Enjoyment 1 Year after Sleeve Gastrectomy: A Prospective Study.袖状胃切除术后 1 年食物选择、味觉、欲望和享受的变化:一项前瞻性研究。
Nutrients. 2022 May 14;14(10):2060. doi: 10.3390/nu14102060.
9
Lipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity.袖状胃切除术可降低中国肥胖成年人的脂多糖和炎症细胞因子水平。
Endocr J. 2019 Apr 25;66(4):337-347. doi: 10.1507/endocrj.EJ18-0446. Epub 2019 Feb 22.
10
Changes in Plasma Growth Differentiation Factor-15 After Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients: A Prospective Study.病态肥胖患者腹腔镜袖状胃切除术后血浆生长分化因子-15的变化:一项前瞻性研究
J Inflamm Res. 2021 Apr 12;14:1365-1373. doi: 10.2147/JIR.S304929. eCollection 2021.

引用本文的文献

1
GDF15: An emerging disease target and biomarker of metabolic diseases.生长分化因子15:一种新兴的代谢性疾病治疗靶点和生物标志物
J Endocrinol Invest. 2025 Jun 26. doi: 10.1007/s40618-025-02636-y.
2
Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery.生长分化因子15作为减肥手术后临床结局生物标志物的相关性。
J Endocrinol. 2025 Jul 1;266(1). doi: 10.1530/JOE-25-0010.
3
Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes.
减肥手术对循环中生长分化因子15(GDF15)和成纤维细胞生长因子21(FGF21)水平的不同影响:对血糖状态和体重减轻结果的影响。
Eur J Clin Invest. 2025 Oct;55(10):e70069. doi: 10.1111/eci.70069. Epub 2025 May 16.
4
Sleeve Gastrectomy Preferentially Increases GDF15 Plasma Levels in Patients With Obesity but Without Metabolic Syndrome.袖状胃切除术优先提高肥胖但无代谢综合征患者的血浆生长分化因子15水平。
Obes Surg. 2025 Jan;35(1):341-344. doi: 10.1007/s11695-024-07625-3. Epub 2024 Dec 11.
5
Correlations between growth differentiation factor 15 (GDF-15) serum levels and gene polymorphism with type 2 diabetes mellitus.生长分化因子15(GDF - 15)血清水平及基因多态性与2型糖尿病的相关性
Heliyon. 2024 Jun 13;10(12):e33044. doi: 10.1016/j.heliyon.2024.e33044. eCollection 2024 Jun 30.
6
Obesity and the kidney: mechanistic links and therapeutic advances.肥胖与肾脏:机制关联与治疗进展。
Nat Rev Endocrinol. 2024 Jun;20(6):321-335. doi: 10.1038/s41574-024-00951-7. Epub 2024 Feb 13.
7
Novel Insights into the Physiology of Nutrient Sensing and Gut-Brain Communication in Surgical and Experimental Obesity Therapy.手术和实验性肥胖治疗中营养感应和肠道-大脑通讯生理学的新见解。
Obes Surg. 2023 Sep;33(9):2906-2916. doi: 10.1007/s11695-023-06739-4. Epub 2023 Jul 20.
8
Mechanisms of bariatric surgery for weight loss and diabetes remission.减重手术治疗肥胖和糖尿病缓解的机制。
J Diabetes. 2023 Sep;15(9):736-752. doi: 10.1111/1753-0407.13443. Epub 2023 Jul 13.
9
Alteration of BDNF, SPARC, FGF-21, and GDF-15 circulating levels after 1 year of anti-obesity treatments and their association with 1-year weight loss.抗肥胖治疗 1 年后 BDNF、SPARC、FGF-21 和 GDF-15 循环水平的改变及其与 1 年体重减轻的关系。
Endocrine. 2023 Oct;82(1):57-68. doi: 10.1007/s12020-023-03435-2. Epub 2023 Jul 12.
10
GDF15 and Cortisol Response to Meal Tolerance Test in Post-Sleeve Gastrectomy Patients with Weight Regain.胃旁路术后体重反弹患者对餐耐量试验的 GDF15 和皮质醇反应。
Obes Surg. 2022 Aug;32(8):2641-2648. doi: 10.1007/s11695-022-06140-7. Epub 2022 Jun 8.